Alternative splicing of CYP2D mRNA - A putative regulatory mechanism

被引:0
|
作者
Kaminsky, LS
Huang, Z
机构
[1] Wadsworth Ctr, Albany, NY USA
[2] SUNY Albany, Albany, NY 12222 USA
来源
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P282
引用
收藏
页码:A819 / A819
页数:1
相关论文
共 50 条
  • [1] Alternative splicing of CYP2D mRNA in human breast tissue
    Huang, ZQ
    Fasco, MJ
    Kaminsky, LS
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 343 (01) : 101 - 108
  • [2] Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disorders
    Woo, SI
    Hansen, LA
    Yu, X
    Mallory, M
    Masliah, E
    NEUROLOGY, 1999, 53 (07) : 1570 - 1572
  • [3] CYP2D mRNA analysis in conventional and mini pigs
    Skaanild, MT
    Friis, C
    DRUG METABOLISM REVIEWS, 2002, 34 : 61 - 61
  • [4] In situ hybridization study of CYP2D mRNA in the common marmoset brain
    Shimamoto, Yoshinori
    Niimi, Kimie
    Kitamura, Hiroshi
    Tsubakishita, Sae
    Takahashi, Eiki
    EXPERIMENTAL ANIMALS, 2016, 65 (04) : 465 - 471
  • [5] Alternative splicing of CYP2B2 mRNA in rat liver
    Mezentsev, AN
    Gulyaeva, LF
    Grishanova, AY
    Kovalenko, SP
    Lyakhovich, VV
    FASEB JOURNAL, 1997, 11 (09): : A815 - A815
  • [6] CYP2D is involved in neurosteroidogenesis in the brain
    Kishimoto, W
    Hiroi, T
    Osada, M
    Imaoka, S
    Igarashi, T
    Fuane, Y
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 223 - 225
  • [7] The endogenous substrates of brain CYP2D
    Wang, Xiaoshuang
    Li, Jie
    Dong, Guicheng
    Yue, Jiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 211 - 218
  • [8] CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response
    Tyndale, R.
    Miksys, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S119 - S119
  • [9] Oxidation of debrisoquine by marmoset CYP2D enzymes, CYP2D19 and CYP2D30
    Narimatsu, S
    Kuramoto, S
    Hichiya, H
    Yamamoto, S
    Asaoka, K
    Miyata, A
    Kiryu, K
    Ueda, N
    Naito, S
    Ellis, SW
    DRUG METABOLISM REVIEWS, 2003, 35 : 192 - 192
  • [10] Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine
    Lin, LY
    Fujimoto, M
    Distefano, EW
    Schmitz, DA
    Jayasinghe, A
    Cho, AK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (02): : 595 - 603